...
首页> 外文期刊>Current Diabetes Reviews >Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model
【24h】

Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model

机译:2型糖尿病肾病的发病机制和治疗:自发性KK / Ta小鼠模型的教训

获取原文
获取原文并翻译 | 示例

摘要

Diabetic nephropathy is a major cause of end-stage renal failure (ESRF) in patients with both type 1 and type 2ndiabetes. Many factors such as genetic and non-genetic promoters, hypertension, hyperglycemia, accumulation ofnadvanced glycation end products (AGEs), dyslipidemia, albuminuria and proteinuria influence the progression of thisndesease. It is important to determine pathogenesis and treatment of this disease. However, it is difficult to investigate sincenhuman diabetes is a heterogeneous and multifactorial disease. Therefore, most of these mechanisms have beenninvestigated in animal experiments. KK/Ta mice have a clearly different genetic background in terms of body weight,nblood glucose, impaired glucose tolerance (IGT), urinary albumin excretion and serum triglyceride than BALB/c mice.nRenal lesions of KK/Ta mice closely resemble those in human early diabetic nephropathy. Thus, the KK/Ta mouse maynserve as a suitable model for the study of type 2 diabetes and early diabetic nephropathy in humans. We reviewed geneticnsusceptibility using genome-wide linkage analysis and differential display polymerase chain reaction (DD-PCR) ornNorthern blot analysis, and treatment of diabetic nephropathy using angiotensin type 1 (AT1) receptor blockers (ARB) ornthiazolidinediones (TZDs) in KK/Ta mice.
机译:糖尿病性肾病是1型和2型糖尿病患者终末期肾衰竭(ESRF)的主要原因。遗传和非遗传启动子,高血压,高血糖,糖化终末产物(AGEs)积累,血脂异常,蛋白尿和蛋白尿等许多因素都会影响该酶的进程。确定该疾病的发病机理和治疗方法很重要。但是,由于人类糖尿病是一种异质和多因素疾病,因此很难进行调查。因此,大多数这些机制尚未在动物实验中进行研究。与BALB / c小鼠相比,KK / Ta小鼠在体重,血糖,糖耐量受损(IGT),尿白蛋白排泄和血清甘油三酸酯方面具有明显不同的遗传背景。KK / Ta小鼠的肾脏病变与人类的病变非常相似早期糖尿病肾病。因此,KK / Ta小鼠可作为研究人类2型糖尿病和早期糖尿病肾病的合适模型。我们审查了遗传敏感性使用全基因组连锁分析和差异显示聚合酶链反应(DD-PCR)ornNorthern印迹分析,并在KK / Ta小鼠中使用1型血管紧张素(AT1)受体阻滞剂(ARB)邻苯二氮烷二酮(TZDs)治疗糖尿病肾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号